glp-1 drugs tirzepatide Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with among patients with type 2 diabetes, a large retrospective cohort Tirzepatide vs. Semaglutide: What You

It is, therefore, important to have liver-specific treatments for patients who have already advanced liver disease

At PlexusDx, we emphasize that genetic predispositions in peptide pathways may provide context for understanding individual variation in GLP-1 responseinformation that can support more personalized treatment discussions

doi:10.2165/00003088-199325020-00003 213

Doyle ME, Egan JM

[DOI] [PubMed] [Google Scholar] 125.Shapiro S.B., Yin H., Yu O.H.Y., Rej S., Suissa S., Azoulay L

Understanding your options and what to expect Delivery timing and how the process works General questions before you decide Potential Risks and Gastrointestinal Side Effects Gastrointestinal side effects are the most commonly reported adverse reactions with GLP-1 receptor agonists, occurring in a significant proportion of patients, particularly during treatment initiation and dose escalation